title: Photodynamic therapy with verteporfin in laser-induced choroidal neovascularization.
abstract: OBJECTIVE
  To report a case of laser-induced choroidal neovascularization (CNV) treated with verteporfin photodynamic therapy.
  
  
  METHODS
  Interventional case report.
  
  
  METHODS
  A patient developed CNV in the macular area of the left eye 2 years following grid laser for macular edema secondary to branch retinal vein occlusion.
  
  
  RESULTS
  The CNV was controlled with one session of photodynamic therapy. Lesion decreased in size, contracting to a smaller subretinal fibrotic scar. Vision improved from 20/200 to 20/100, and there was no recurrence at 2-year follow-up. No complications were encountered.
  
  
  CONCLUSIONS
  Laser-induced CNV can be safely and effectively treated by photodynamic therapy.
authors.affiliation: Hong Kong Eye Hospital, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Kowloon, Hong Kong. cwm6373@netvigator.com
authors.forename: Wai-Man
authors.initials: WM
authors.lastname: Chan
authors.forename: Kenneth K W
authors.initials: KK
authors.lastname: Li
authors.forename: David T L
authors.initials: DT
authors.lastname: Liu
authors.forename: Timothy Y Y
authors.initials: TY
authors.lastname: Lai
authors.forename: Kelvin K L
authors.initials: KK
authors.lastname: Chong
authors.forename: Dennis S C
authors.initials: DS
authors.lastname: Lam
mesh_terms: D000328:Adult; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007049:Iatrogenic Disease; D017075:Laser Coagulation / Q000009:adverse effects*; D008269:Macular Edema / Q000209:etiology; D008297:Male; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D012170:Retinal Vein Occlusion / Q000150:complications / Q000601:surgery; D000077362:Verteporfin; D014792:Visual Acuity
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin